医学
心脏病学
脉冲波速
射血分数
内科学
心力衰竭
危险系数
外围设备
血压
置信区间
作者
Masafumi Takae,Eiichiro Yamamoto,Takanori Tokitsu,Fumi Oike,Taiki Nishihara,Koichiro Fujisue,Daisuke Sueta,Hiroki Usuku,Kota Motozato,Miwa Ito,Hisanori Kanazawa,Satoshi Araki,Taishi Nakamura,Yuichiro Arima,Seiji Takashio,Satoru Suzuki,Kenji Sakamoto,Hirofumi Soejima,Hiroshige Yamabe,Koichi Kaikita
摘要
Abstract BACKGROUND Although pulse wave velocity (PWV) is recognized to be a risk predictor for various cardiovascular diseases, the association of brachial–ankle PWV (baPWV) with cardiovascular outcomes in heart failure (HF) with reduced ejection fraction (HFrEF) patients remains uncertain. METHODS We measured ankle-brachial pressure index (ABI) and baPWV values at stable condition after optimal therapy for HF in 201 consecutive HFrEF patients admitted to Kumamoto University Hospital from 2007 to 2015 who were enrolled and followed until the occurrence of cardiovascular events. We defined peripheral artery disease (PAD) as ABI value ≤ 0.9. RESULTS Kaplan–Meier analysis revealed that HFrEF patients with peripheral artery disease PAD had a significant higher risk of total cardiovascular and HF-related events than those without PAD (P = 0.03 and P = 0.01, respectively). Next, we divided HFrEF patients without PAD into 3 groups according to baPWV values. In the Kaplan–Meier analysis, total cardiovascular and HF-related events in the highest baPWV group (1,800 cm/second ≤ baPWV) had a significantly higher frequency than those in the mid-level baPWV group (1,400 cm/second ≤ baPWV < 1,800 cm/second) (P = 0.007 and P = 0.004, respectively). The hazard ratio between HFrEF patients in the mid-level baPWV group and those with other baPWV groups was compared after adjustment for other cofounders. The probabilities of HF-related events were significantly higher in the lowest and highest baPWV group. CONCLUSION Identifying complications of PAD and measuring baPWV values in HFrEF patients were useful for predicting their prognosis. Trial Registration: UMIN000034358.
科研通智能强力驱动
Strongly Powered by AbleSci AI